CHGCF:OTCMKTS
Chugai Pharmaceutical Co Ltd
$38.27
arrow_upward
+1.13%(+0.43) 1D
Oct 2, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CHGCF...
Open
$39.92
High
$39.92
Low
$37.45
Mkt. cap
10.13T
Avg. vol.
10.10K
Volume
11.44K
52-wk high
$68.08
52-wk low
$34.79
Beta
1.91
Shares outstanding
1.68B
No. of employees
5K
Open
$39.92
High
$39.92
Low
$37.45
Mkt. cap
10.13T
Avg. vol.
10.10K
Volume
11.44K
52-wk high
$68.08
52-wk low
$34.79
Beta
1.91
Shares outstanding
1.68B
No. of employees
5K
News stories
From web sources and news partners
Benzinga
·
1 hour ago
S&P 500 Index Outlook: Top Catalysts for US Stocks This Week
InteractiveCrypto
·
7 hours ago
The S&P 500 Looks Strong. Underneath, October Looks Thin.
Traders Union
·
2 hours ago
S&P500 has posted gains in nearly every November-through-June period since 1942, Lia Holmgren notes
TradingKey
·
18 hours ago
S&P 500 vs. Nasdaq 100: Which Is Better for Long-Term Investment?
Profile
Chugai Pharmaceutical Co., Ltd. is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014. The company is headquartered in Tokyo. Osamu Nagayama is the current representative director and chairman. Tatsuro Kosaka is the current representative director, president and CEO. Wikipedia
About Chugai Pharmaceutical Co Ltd
CEOOsamu Okuda
Employees5.1K
FoundedMar 10, 1925
Headquarters-
SectorPharmaceutical industry
Websitechugai-pharm.co.jp